Table 3.
Base Case Cost-Effectiveness Results
| Strategy | Undiscounted Life Expectancy (y) | Total Discounted Cost per Person ($) | Remaining QALY per Person (QALY) | Incremental Cost- Effectiveness Ratio ($/QALY) |
|---|---|---|---|---|
| Current practice | 79.0458 | 122080 | 23.7700 | --- |
| Physician-ordered, targeted venipuncture testing | 79.0460 | 122090 | 23.7702 | Dominated |
| Physician-ordered, counselor-performed targeted rapid testing | 79.0461 | 122090 | 23.7702 | 40000 |
| Counselor-initiated, targeted venipuncture testing | 79.0465 | 122100 | 23.7705 | Dominated |
| Physician-ordered, routine venipuncture testing | 79.0463 | 122110 | 23.7704 | Dominated |
| Counselor-initiated, targeted rapid testing | 79.0467 | 122110 | 23.7706 | 44000 |
| Physician ordered, counselor-performed routine rapid testing | 79.0465 | 122110 | 23.7705 | Dominated |
| Counselor-initiated, routine venipuncture testing | 79.0471 | 122140 | 23.7709 | Dominated |
| Counselor-initiated, routine rapid testing | 79.0475 | 122160 | 23.7713 | 71000 |
Costs are rounded to the nearest $10, QALYs to nearest 0.0001, incremental cost-effectiveness ratios to nearest $1000/QALY. Small inconsistencies may be present due to rounding.
Abbreviation: QALY, quality adjusted life-year.